Effect of Clopidogrel Pretreatment on Angiographic and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction

American Journal of Cardiology

Volumn 101, Issue 4, 2008, Pages 435-439

  Lev, Eli I ^a   Kornowski, Ran ^a   Vaknin Assa, Hana ^a   Brosh, David ^a   Fuchs, Shmuel ^a   Battler, Alexander ^a   Assali, Abid ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; DRUG EFFECT; EMERGENCY WARD; FEMALE; HEART MUSCLE PERFUSION; HEART REINFARCTION; HOSPITAL ADMISSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PREMEDICATION; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RETREATMENT; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 38849108074     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.089     Document Type: Article

References (12)

1. Sabatine M.S., Cannon C.P., Gibson C.M., López-Sendón J.L., Montalescot G., Theroux P., Lewis B.S., Murphy S.A., McCabe C.H., Braunwald E., and Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 294 (2005) 1224-1232
2. Gibson C.M., Cannon C.P., Murphy S.A., Ryan K.A., Mesley R., Marble S.J., McCabe C.H., Van De Werf F., and Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
3. Gibson C.M., Cannon C.P., Murphy S.A., Marble S.J., Barron H.V., Braunwald E., and TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105 (2002) 1909-1913
4. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
5. Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E., Cox D.A., Turco M., Stuckey T.D., Na Y., Lansky A.J., Gersh B.J., O'Neill W.W., Mehran R., and Stone G.W. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45 (2005) 1397-1405
6. Hochholzer W., Trenk D., Bestehorn H.P., Fischer B., Valina C.M., Ferenc M., Gick M., Caputo A., Büttner H.J., and Neumann F.J. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48 (2006) 1742-1750
7. Campo G., Valgimigli M., Gemmati D., Percoco G., Tognazzo S., Cicchitelli G., Catozzi L., Malagutti P., Anselmi M., Vassanelli C., Scapoli G., and Ferrari R. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. J Am Coll Cardiol 48 (2006) 2178-2185
8. Montalescot G., Borentain M., Payot L., Collet J.P., and Thomas D. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 292 (2004) 362-366
9. Hochholzer W., Trenk D., Frundi D., Blanke P., Fischer B., Andris K., Bestehorn H.P., Büttner H.J., and Neumann F.J. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 111 (2005) 2560-2564
10. Gurbel P.A., Malinin A.I., Callahan K.P., Serebruany V.L., and O'Connor C.M. Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation. Am J Cardiol 90 (2002) 312-315
11. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Ramírez C., Sabaté M., Bañuelos C., Hernández-Antolín R., Escaned J., Moreno R., Alfonso F., and Macaya C. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. Eur Heart J 25 (2004) 1903-1910
12. Rogers W.J., Canto J.G., Barron H.V., Boscarino J.A., Shoultz D.A., and Every N.R. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. J Am Coll Cardiol 35 (2000) 371-379